Kamalika Moulick, Ph.D.
Affiliations: | 2010 | Weill Cornell Medical College, New York, NY, United States |
Area:
Biomedical Engineering, BiochemistryGoogle:
"Kamalika Moulick"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Gabriela Chiosis | grad student | 2010 | Weill Cornell Medical College | |
| (Understanding the biological relevance of chaperone modulation in transformed systems.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cooper J, Xu Q, Zhou L, et al. (2017) Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss-Driven Tumorigenesis. Molecular Cancer Therapeutics |
| Rodina A, Moulick K, Ahn J, et al. (2012) Abstract 3029: Biochemical evidence towards the existence of an oncogenic Hsp90 complex Cancer Research. 72: 3029-3029 |
| Gomes-DaGama EM, Moulick K, Ahn JH, et al. (2012) Abstract 1263: Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90 Cancer Research. 72: 1263-1263 |
| Moulick K, Ahn JH, Zong H, et al. (2011) Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nature Chemical Biology. 7: 818-26 |
| Taldone T, Zatorska D, Patel PD, et al. (2011) Design, synthesis, and evaluation of small molecule Hsp90 probes. Bioorganic & Medicinal Chemistry. 19: 2603-14 |
| Ahn JH, Luo W, Kim J, et al. (2011) Design of a flexible cell-based assay for the evaluation of heat shock protein 70 expression modulators. Assay and Drug Development Technologies. 9: 236-46 |
| Caldas-Lopes E, Cerchietti L, Ahn JH, et al. (2009) Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models. Proceedings of the National Academy of Sciences of the United States of America. 106: 8368-73 |
| Du Y, Moulick K, Rodina A, et al. (2007) High-throughput screening fluorescence polarization assay for tumor-specific Hsp90. Journal of Biomolecular Screening. 12: 915-24 |
| Rodina A, Vilenchik M, Moulick K, et al. (2007) Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer. Nature Chemical Biology. 3: 498-507 |
| Luo W, Dou F, Rodina A, et al. (2007) Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies. Proceedings of the National Academy of Sciences of the United States of America. 104: 9511-6 |